BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million

Reuters

2025/08/29

Aug 29 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:

H1 GROSS PROFIT RMB 757.3 MILLION
H1 GROSS MARGIN 66.1%
H1 PRETAX PROFIT RMB 156.9 MILLION
H1 REVENUE RMB 1,146.2 MILLION
H1 OPERATING PROFIT RMB 264.4 MILLION
RESOLVED TO DECLARE AN INTERIM CASH DIVIDEND OF RMB0.99 CENTS PER SHARE

Further company coverage: 0460.HK

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2563901238"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2563901238\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2563901238?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-29 16:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2563901238","market":"us","top_or_hot":-1,"title":"BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million</title></head><body><p><span>Aug 29 (Reuters)</span><span> - </span>Sihuan Pharmaceutical Holdings Group Ltd <span>0460.HK</span>:</p><ul><li><p>H1 GROSS PROFIT RMB 757.3 MILLION</p></li><li><p>H1 GROSS MARGIN 66.1%</p></li><li><p>H1 PRETAX PROFIT RMB 156.9 MILLION</p></li><li><p>H1 REVENUE RMB 1,146.2 MILLION</p></li><li><p>H1 OPERATING PROFIT RMB 264.4 MILLION</p></li><li><p>RESOLVED TO DECLARE AN INTERIM CASH DIVIDEND OF RMB0.99 CENTS PER SHARE</p></li></ul><p>Further company coverage: <span>0460.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-29 16:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 Million</title></head><body><p><span>Aug 29 (Reuters)</span><span> - </span>Sihuan Pharmaceutical Holdings Group Ltd <span>0460.HK</span>:</p><ul><li><p>H1 GROSS PROFIT RMB 757.3 MILLION</p></li><li><p>H1 GROSS MARGIN 66.1%</p></li><li><p>H1 PRETAX PROFIT RMB 156.9 MILLION</p></li><li><p>H1 REVENUE RMB 1,146.2 MILLION</p></li><li><p>H1 OPERATING PROFIT RMB 264.4 MILLION</p></li><li><p>RESOLVED TO DECLARE AN INTERIM CASH DIVIDEND OF RMB0.99 CENTS PER SHARE</p></li></ul><p>Further company coverage: <span>0460.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1515","symbol_name":"抗疫概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nPLXA63585:1","article_id":"2563901238","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2563901238","pubTimestamp":1756455151,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 MillionAug 29  - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:H1 GROSS PROFIT RMB 757.3 MILLIONH1 GROSS MARGIN 66.1%H1 PRETAX PROFIT RMB 156.9 MILLIONH1 REVENUE RMB 1,146.2 MILLIONH1 OPERATING PROFIT RMB 264.4 MILLIONRESOLVED TO DECLARE AN INTERIM CASH DIVIDEND OF RMB0.99 CENTS PER SHAREFurther company coverage: 0460.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1515":"抗疫概念","BK1191":"制药","BK1600":"工业大麻","BK1593":"医美概念股","00460":"四环医药"},"translate_title":"简报-四环医药上半年毛利人民币757.3百万元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00460":0.9},"content_text":"BRIEF-Sihuan Pharmaceutical Posts H1 Gross Profit RMB757.3 MillionAug 29 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:H1 GROSS PROFIT RMB 757.3 MILLIONH1 GROSS MARGIN 66.1%H1 PRETAX PROFIT RMB 156.9 MILLIONH1 REVENUE RMB 1,146.2 MILLIONH1 OPERATING PROFIT RMB 264.4 MILLIONRESOLVED TO DECLARE AN INTERIM CASH DIVIDEND OF RMB0.99 CENTS PER SHAREFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}